Method Name
A short description of the method used to perform the test
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test
Electron Transport Chain Enzymes
Aliases
Lists additional common names for a test, as an aid in searching
Cytochrome c Oxidase Deficiency
Electron Transport Chain Enzymes
Leigh Syndrome due to Cytochrome c Oxidase Deficiency
Mitochondrial Respiratory Chain Complex I Deficiency (mitochondrial genes)
Mitochondrial Respiratory Chain Complex I Deficiency (nuclear genes)
Mitochondrial Respiratory Chain Complex I Deficiency
Mitochondrial Respiratory Chain Enzymes
Respiratory Chain Complexes
Specimen Type
Describes the specimen type validated for testing
Fibroblasts
Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
Cultured Fibroblasts
3 T-25 flasks(s) filled to neck with culture media. Maintain sterility and forward promptly at ambient temperature.
Complete and submit with specimen:
1. Baylor Mitochondrial request form.
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
Hemolysis NA
Thawing NA
Lipemia NA
Icterus NA
Other NA
Specimen Type |
Temperature |
Time |
Special Container |
Fibroblasts |
Ambient |
|
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
A final report will be attached in Mayo Access.
Clinical Reference
Recommendations for in-depth reading of a clinical nature
Kirby DM, Thorburn DR, Turnbull DM, Taylor RW. Biochemical assays of respiratory chain complex activity. Methods Cell Biol, 2007; 80:93-119.
Trounce, I.A., Kim, Y.L., Jun, A.S., Wallace, D.C. Assessment of mitochondrial oxidative phosphorylation in patients muscle biopsies, lymphoblasts and transmitochondrial cell lines. Methods Enzymol, 1996. 264, 484-509.
Gellerich, F.N. et al. (2004) The problem of interlab variation in methods mitochondrial disease diagnosis: enzymatic measurement of respiratory chain complexes. Mitochondrion 4, (427-439)
Enns, G.M. et al. (2005) ReIatonship of primary mitochondrial respiratory chain· dysfunction to fiber type abnormalities in skeletal muscle. Clin. Genet. 66: 337-346. Bernier, FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR (2002) diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59, 1406-11.
Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol 36, 260-267.
Method Description
Describes how the test is performed and provides a method-specific reference
The electron transport chain enzymes were assayed at 30 C using a temperature-controlled spectrophotometer. Each assay is performed in duplicate. The activities of complex I (NADH:Ferricyanide dehydrogenase), complex II (succinate- dehydrogenase), complex I+III (NADH:cytochrome c oxidoreductase), complex II+III (succinate:cytochrome c reductase) and complex IV (cytochrome c oxidase) were measured using different electron acceptors/donors. The increase or decrease of cytochrome c at 550 nm was measured for complex I+III, II+III, or complex IV. The activity of complex I was measured-by following the oxidation of NADH at 340 nm. For complex II, the reduction of 2, 6-dichloroindophenol (DCIP) at 600 nm was measured. Citrate synthase is used as a marker for mitochondrial content. Enzyme activities are normalized against citrate synthase (CS) activity when CS activity is greater than 1 standard deviation above or below the control mean. The second figures in parentheses represent data after normalization if it has been performed. The interpretation of the results is done on the assumption that the specimen has been handled properly.
PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information
Referral
Upon receipt
Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.
42 to 45 days
Baylor Medical Genetics Laboratories